fortrea

Displaying 581 - 590 of 697

Expert

Zehra Nurgul Pamuklar MD, PhD

Senior Medical Director

Zehra Nurgul Pamuklar, MD, PhD, is a Senior Medical Director of Oncology for Fortrea, based in Cary, North Carolina. Dr.

Photo of
<span>Zehra Nurgul Pamuklar MD, PhD</span>

Expert

Yulianna Tymovska, MD, PhD

Senior Medical Director

Yulianna Tymovska, MD, PhD, is Senior Medical Director based in Brisbane, Australia. Dr.

Photo of
<span>Yulianna Tymovska, MD, PhD</span>

Expert

Victor Angélico, MD

Senior Director, Strategic Delivery & Growth

Victor Angélico, MD, is a Senior Medical Director for Fortrea, based in Paris, France. He provides clinical and medical expertise to project teams and other Fortrea departments to advance clients’ drug development programs. Dr.

Photo of
<span>Victor Angélico, MD</span>

Expert

Verena Schnackenbeck

Senior Director, Strategic Delivery & Growth

Verena brings more than 25 years of clinical research experience, with 17 years in global project management across Phase I to Phase IV.

Photo of
<span>Verena Schnackenbeck</span>

Expert

Veerle Van De Velde, MD

Senior Medical Director

Veerle Van De Velde, MD, currently works as a Global Project physician in the IGM therapeutic area (TA).

Photo of
<span>Veerle Van De Velde, MD</span>

Expert

Tanya Richardson

Strategy Head, Ophthalmology and Neuroscience

Tanya has over 28 years of experience with Fortrea (formerly Labcorp, Covance and Chiltern), including monitoring, global project management, delivery director oversight and strategic planning and growth.

Mobile Clinical Services

Fortrea provides mobile healthcare solutions and clinical trial mobility. Explore our remote healthcare services for efficient trial management.

Diversity & Inclusion in Clinical Trials

Fortrea promotes diversity and inclusion in clinical trials to ensure equitable research and minority participation. Learn more about our inclusive trial strategies.

Clinical Development

Rely on Fortrea's comprehensive suite of clinical development services to bring your compound from bench to bedside.

Blog 9 October 2024

Advanced therapies: The advantage of early and frequent regulatory interactions

Navigating the dynamic regulatory environment in cell and gene therapy development involves a complex and iterative process.

Book a Meeting